An enteric coating did not hurt the effectiveness of aspirin pills for secondary prevention of atherosclerotic cardiovascular disease (ASCVD), but it didn't make it any safer either, researchers found ...

A recent analysis from the large ADAPTABLE trial published in JAMA Cardiology showed that enteric coating on aspirin does not change effectiveness or safety for patients with cardiovascular disease.

Clinical trials and meta-analyses have suggested that aspirin may be effective for the prevention of venous thromboembolism (proximal deep-vein thrombosis or pulmonary embolism) after total hip or ...

Please provide your email address to receive an email when new articles are posted on . Among patients with atherosclerotic CVD, there was no difference in CV events or major bleeding according to ...

PLx Pharma has won FDA approval for its liquid-filled aspirin capsule Vazalore. The formulation has bettered enteric-coated and immediate-release aspirin in some regards in clinical trials. Aspirin is ...